Journal
Journal of Clinical Oncology
Publication Date
11-10-2023
Volume
41
Issue
32
First Page
5005
Last Page
5014
Document Type
Open Access Publication
DOI
10.1200/JCO.23.00617
Rights and Permissions
Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU; Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. J Clin Oncol. 2023 Nov 10;41(32):5005-5014. doi: 10.1200/JCO.23.00617. © 2023 by American Society of Clinical Oncology. Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
Recommended Citation
Roy, Soumyajit; Michalski, Jeff M; and et al., "Biochemical recurrence surrogacy for clinical outcomes after radiotherapy for adenocarcinoma of the prostate." Journal of Clinical Oncology. 41, 32. 5005 - 5014. (2023).
https://digitalcommons.wustl.edu/oa_4/3341
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
